SIMILAR PATTERNS OF AMINO ACIDS FOR 4QRC_A_0LIA802_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1coy | CHOLESTEROL OXIDASE (Brevibacteriumsterolicum) |
PF00732(GMC_oxred_N)PF05199(GMC_oxred_C) | 5 | ALA A 27LEU A 298ALA A 288ASP A 474LEU A 477 | NoneNoneNoneFAD A 510 (-4.7A)None | 1.11A | 4qrcA-1coyA:undetectable | 4qrcA-1coyA:18.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1jr1 | INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE 2 (Cricetulusgriseus) |
PF00478(IMPDH)PF00571(CBS) | 5 | ALA A 248MET A 290VAL A 271ALA A 264ASP A 261 | None | 1.07A | 4qrcA-1jr1A:undetectable | 4qrcA-1jr1A:21.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1k9a | CARBOXYL-TERMINALSRC KINASE (Rattusnorvegicus) |
PF00017(SH2)PF00018(SH3_1)PF07714(Pkinase_Tyr) | 5 | ALA A 220GLU A 236MET A 240LEU A 305ARG A 313 | None | 0.72A | 4qrcA-1k9aA:31.3 | 4qrcA-1k9aA:30.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1o8c | YHDH (Escherichiacoli) |
PF00107(ADH_zinc_N)PF08240(ADH_N) | 5 | ALA A 176VAL A 152LEU A 282ALA A 165LEU A 170 | None | 1.13A | 4qrcA-1o8cA:undetectable | 4qrcA-1o8cA:23.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1opk | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 (Mus musculus) |
PF00017(SH2)PF00018(SH3_1)PF07714(Pkinase_Tyr) | 6 | ALA A 288GLU A 305MET A 309LEU A 373ARG A 381ALA A 399 | P16 A 2 (-3.4A)P16 A 2 (-4.2A)P16 A 2 (-3.3A)NoneNoneP16 A 2 (-3.5A) | 0.83A | 4qrcA-1opkA:30.7 | 4qrcA-1opkA:29.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1py5 | TGF-BETA RECEPTORTYPE I (Homo sapiens) |
PF00069(Pkinase)PF08515(TGF_beta_GS) | 5 | ALA A 230GLU A 245LEU A 316ARG A 332ALA A 350 | PY1 A 700 (-3.5A)PY1 A 700 ( 4.9A)NoneNonePY1 A 700 ( 4.2A) | 0.59A | 4qrcA-1py5A:26.1 | 4qrcA-1py5A:27.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1tqy | ACTINORHODINPOLYKETIDE PUTATIVEBETA-KETOACYLSYNTHASE 1ACTINORHODINPOLYKETIDE PUTATIVEBETA-KETOACYLSYNTHASE 2 (Streptomycescoelicolor) |
PF00109(ketoacyl-synt)PF02801(Ketoacyl-synt_C) | 5 | ALA B 75GLU B 229VAL B 187LEU A 143LEU B 191 | None | 1.15A | 4qrcA-1tqyB:undetectable | 4qrcA-1tqyB:24.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ujn | DEHYDROQUINATESYNTHASE (Thermusthermophilus) |
PF01761(DHQ_synthase) | 6 | ALA A 208VAL A 209LEU A 255ARG A 276ALA A 174LEU A 187 | None | 1.27A | 4qrcA-1ujnA:undetectable | 4qrcA-1ujnA:24.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1v71 | HYPOTHETICAL PROTEINC320.14 INCHROMOSOME III (Schizosaccharomycespombe) |
PF00291(PALP) | 5 | ALA A 16GLU A 170VAL A 13LEU A 178ALA A 164 | None | 1.15A | 4qrcA-1v71A:undetectable | 4qrcA-1v71A:20.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2dq7 | PROTO-ONCOGENETYROSINE-PROTEINKINASE FYN (Homo sapiens) |
PF07714(Pkinase_Tyr) | 5 | ALA X 37GLU X 54MET X 58ARG X 129ALA X 147 | STU X 902 (-3.1A)STU X 902 ( 4.4A)NonePTR X 160 ( 3.4A)STU X 902 ( 4.1A) | 0.70A | 4qrcA-2dq7X:31.7 | 4qrcA-2dq7X:34.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2hk5 | TYROSINE-PROTEINKINASE HCK (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 271GLU A 288MET A 292ARG A 363ALA A 381ASP A 382 | 1BM A 499 (-3.6A)1BM A 499 (-3.2A)1BM A 499 ( 3.8A)None1BM A 499 ( 3.7A)1BM A 499 (-4.4A) | 1.37A | 4qrcA-2hk5A:31.2 | 4qrcA-2hk5A:39.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2hz0 | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 269GLU A 286MET A 290ARG A 362ALA A 380ASP A 381 | GIN A 600 (-3.1A)GIN A 600 (-3.6A)GIN A 600 (-3.2A)NoneGIN A 600 (-3.1A)GIN A 600 (-4.9A) | 1.09A | 4qrcA-2hz0A:31.7 | 4qrcA-2hz0A:40.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2hz0 | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 269GLU A 286MET A 290LEU A 354ARG A 362ALA A 380 | GIN A 600 (-3.1A)GIN A 600 (-3.6A)GIN A 600 (-3.2A)GIN A 600 ( 4.6A)NoneGIN A 600 (-3.1A) | 0.82A | 4qrcA-2hz0A:31.7 | 4qrcA-2hz0A:40.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2og8 | PROTO-ONCOGENETYROSINE-PROTEINKINASE LCK (Homo sapiens) |
PF07714(Pkinase_Tyr) | 5 | ALA A 271ARG A 363ALA A 381ASP A 382PHE A 383 | 1N8 A 501 ( 3.4A)None1N8 A 501 ( 3.3A)1N8 A 501 ( 3.3A)1N8 A 501 ( 4.3A) | 1.16A | 4qrcA-2og8A:31.4 | 4qrcA-2og8A:39.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2og8 | PROTO-ONCOGENETYROSINE-PROTEINKINASE LCK (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 271GLU A 288MET A 292ALA A 381ASP A 382PHE A 383 | 1N8 A 501 ( 3.4A)1N8 A 501 ( 3.6A)1N8 A 501 ( 3.6A)1N8 A 501 ( 3.3A)1N8 A 501 ( 3.3A)1N8 A 501 ( 4.3A) | 0.94A | 4qrcA-2og8A:31.4 | 4qrcA-2og8A:39.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ogv | MACROPHAGECOLONY-STIMULATINGFACTOR 1 RECEPTORPRECURSOR (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 614GLU A 633MET A 637LEU A 769CYH A 774ARG A 777 | None | 0.69A | 4qrcA-2ogvA:33.3 | 4qrcA-2ogvA:45.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2p4i | ANGIOPOIETIN-1RECEPTOR (Homo sapiens) |
PF07714(Pkinase_Tyr) | 5 | ALA A 853ARG A 963ALA A 981ASP A 982PHE A 983 | MR9 A 301 (-3.5A)NoneMR9 A 301 (-3.2A)MR9 A 301 (-4.2A)MR9 A 301 (-4.4A) | 1.11A | 4qrcA-2p4iA:27.9 | 4qrcA-2p4iA:43.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2p4i | ANGIOPOIETIN-1RECEPTOR (Homo sapiens) |
PF07714(Pkinase_Tyr) | 5 | ALA A 853LEU A 955ARG A 963ALA A 981PHE A 983 | MR9 A 301 (-3.5A)MR9 A 301 (-4.4A)NoneMR9 A 301 (-3.2A)MR9 A 301 (-4.4A) | 0.68A | 4qrcA-2p4iA:27.9 | 4qrcA-2p4iA:43.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2psq | FIBROBLAST GROWTHFACTOR RECEPTOR 2 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 8 | ALA A 515GLU A 534MET A 538VAL A 564LEU A 617CYH A 622ARG A 625ALA A 643 | NoneNoneNoneNoneNoneNoneSO4 A 303 ( 2.9A)None | 0.70A | 4qrcA-2psqA:36.4 | 4qrcA-2psqA:66.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2r2p | EPHRIN TYPE-ARECEPTOR 5 (Homo sapiens) |
PF07714(Pkinase_Tyr)PF14575(EphA2_TM) | 5 | ALA A 705GLU A 724MET A 728LEU A 791ARG A 799 | NoneNoneNoneNoneSO4 A 1 ( 3.1A) | 1.08A | 4qrcA-2r2pA:32.2 | 4qrcA-2r2pA:32.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xik | SERINE/THREONINEPROTEIN KINASE 25 (Homo sapiens) |
PF00069(Pkinase) | 5 | ALA A 47GLU A 66LEU A 131ARG A 139ALA A 157 | J60 A1294 (-3.3A)NoneNoneTPO A 174 ( 2.9A)J60 A1294 ( 4.2A) | 0.85A | 4qrcA-2xikA:18.7 | 4qrcA-2xikA:26.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2z8c | INSULIN RECEPTOR (Homo sapiens) |
PF07714(Pkinase_Tyr) | 5 | ALA A1028GLU A1047MET A1051LEU A1123ARG A1131 | S91 A 1 (-3.2A)NoneNoneNonePTR A1163 ( 3.6A) | 0.99A | 4qrcA-2z8cA:31.4 | 4qrcA-2z8cA:37.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ayf | NITRIC OXIDEREDUCTASE (Geobacillusstearothermophilus) |
PF00115(COX1) | 5 | ALA A 375VAL A 456ALA A 477PHE A 518LEU A 472 | None | 0.94A | 4qrcA-3ayfA:undetectable | 4qrcA-3ayfA:18.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3b2t | FIBROBLAST GROWTHFACTOR RECEPTOR 2 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 7 | ALA A 515GLU A 534MET A 538VAL A 564LEU A 617CYH A 622ARG A 625 | M33 A1996 (-3.3A)NoneNoneNoneNoneNoneNone | 0.96A | 4qrcA-3b2tA:27.8 | 4qrcA-3b2tA:74.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3b2t | FIBROBLAST GROWTHFACTOR RECEPTOR 2 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 7 | ALA A 515MET A 538VAL A 564LEU A 617CYH A 622ARG A 625ALA A 643 | M33 A1996 (-3.3A)NoneNoneNoneNoneNoneNone | 0.80A | 4qrcA-3b2tA:27.8 | 4qrcA-3b2tA:74.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3c1x | HEPATOCYTE GROWTHFACTOR RECEPTOR (Homo sapiens) |
PF07714(Pkinase_Tyr) | 5 | GLU A1127MET A1131LEU A1195ALA A1221ASP A1222 | CKK A1500 (-3.4A)CKK A1500 (-3.4A)CKK A1500 (-4.4A)CKK A1500 (-3.4A)CKK A1500 (-4.5A) | 1.16A | 4qrcA-3c1xA:24.4 | 4qrcA-3c1xA:32.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3c4f | BASIC FIBROBLASTGROWTH FACTORRECEPTOR 1 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 7 | ALA A 512GLU A 531MET A 535VAL A 561LEU A 614ARG A 622ALA A 640 | C4F A 1 (-3.3A)NoneC4F A 1 ( 3.7A)C4F A 1 ( 4.8A)NoneNoneC4F A 1 (-3.6A) | 0.92A | 4qrcA-3c4fA:40.3 | 4qrcA-3c4fA:70.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3c4f | BASIC FIBROBLASTGROWTH FACTORRECEPTOR 1 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 7 | ALA A 512GLU A 531MET A 535VAL A 561LEU A 614CYH A 619ALA A 640 | C4F A 1 (-3.3A)NoneC4F A 1 ( 3.7A)C4F A 1 ( 4.8A)NoneNoneC4F A 1 (-3.6A) | 0.46A | 4qrcA-3c4fA:40.3 | 4qrcA-3c4fA:70.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3c4f | BASIC FIBROBLASTGROWTH FACTORRECEPTOR 1 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 7 | GLU A 531MET A 535VAL A 561LEU A 614ARG A 622ALA A 640PHE A 489 | NoneC4F A 1 ( 3.7A)C4F A 1 ( 4.8A)NoneNoneC4F A 1 (-3.6A)C4F A 1 (-3.7A) | 1.18A | 4qrcA-3c4fA:40.3 | 4qrcA-3c4fA:70.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3d7u | TYROSINE-PROTEINKINASE CSK (Homo sapiens) |
PF07714(Pkinase_Tyr) | 5 | ALA A 220GLU A 236MET A 240LEU A 305ARG A 313 | None | 0.72A | 4qrcA-3d7uA:25.5 | 4qrcA-3d7uA:40.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3dko | EPHRIN TYPE-ARECEPTOR 7 (Homo sapiens) |
PF07714(Pkinase_Tyr)PF14575(EphA2_TM) | 5 | ALA A 663GLU A 682MET A 686LEU A 749PHE A 777 | IHZ A1001 (-3.3A)IHZ A1001 (-3.8A)IHZ A1001 (-3.5A)NoneIHZ A1001 (-4.7A) | 0.80A | 4qrcA-3dkoA:31.7 | 4qrcA-3dkoA:32.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3h7v | O-SUCCINYLBENZOATESYNTHASE (Thermosynechococcuselongatus) |
PF13378(MR_MLE_C) | 5 | ALA A 271GLU A 54CYH A 63PHE A 87LEU A 82 | None | 1.15A | 4qrcA-3h7vA:undetectable | 4qrcA-3h7vA:21.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3hng | VASCULAR ENDOTHELIALGROWTH FACTORRECEPTOR 1 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 5 | ALA A 859GLU A 878VAL A 909ARG A1021ASP A1040 | 8ST A2001 ( 3.8A)8ST A2001 (-3.7A)8ST A2001 (-4.1A)NoneNone | 1.04A | 4qrcA-3hngA:35.1 | 4qrcA-3hngA:45.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3hng | VASCULAR ENDOTHELIALGROWTH FACTORRECEPTOR 1 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 5 | ALA A 859GLU A 878VAL A 909ARG A1021PHE A1041 | 8ST A2001 ( 3.8A)8ST A2001 (-3.7A)8ST A2001 (-4.1A)None8ST A2001 ( 3.7A) | 1.01A | 4qrcA-3hngA:35.1 | 4qrcA-3hngA:45.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3hng | VASCULAR ENDOTHELIALGROWTH FACTORRECEPTOR 1 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 859GLU A 878VAL A 909LEU A1013CYH A1018ARG A1021 | 8ST A2001 ( 3.8A)8ST A2001 (-3.7A)8ST A2001 (-4.1A)8ST A2001 (-4.6A)8ST A2001 ( 4.7A)None | 0.73A | 4qrcA-3hngA:35.1 | 4qrcA-3hngA:45.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hu5 | ISOCHORISMATASEFAMILY PROTEIN (Desulfovibriovulgaris) |
PF00857(Isochorismatase) | 5 | ALA A 12VAL A 131ALA A 147ASP A 146PHE A 112 | None | 1.02A | 4qrcA-3hu5A:undetectable | 4qrcA-3hu5A:21.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3k11 | PUTATIVE GLYCOSYLHYDROLASE (Bacteroidesthetaiotaomicron) |
PF07470(Glyco_hydro_88) | 5 | ALA A 382VAL A 381LEU A 293ALA A 426LEU A 356 | None | 1.18A | 4qrcA-3k11A:undetectable | 4qrcA-3k11A:21.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3kul | EPHRIN TYPE-ARECEPTOR 8 (Homo sapiens) |
PF07714(Pkinase_Tyr)PF14575(EphA2_TM) | 5 | ALA A 665GLU A 684MET A 688LEU A 751ARG A 759 | None | 0.96A | 4qrcA-3kulA:32.7 | 4qrcA-3kulA:34.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3mdy | BONE MORPHOGENETICPROTEIN RECEPTORTYPE-1B (Homo sapiens) |
PF07714(Pkinase_Tyr)PF08515(TGF_beta_GS) | 5 | ALA A 229GLU A 244LEU A 315ARG A 331ALA A 349 | LDN A 1 (-3.6A)NoneNoneNoneLDN A 1 ( 3.8A) | 0.90A | 4qrcA-3mdyA:25.9 | 4qrcA-3mdyA:29.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3n54 | SPORE GERMINATIONPROTEIN B3 (Bacillussubtilis) |
PF05504(Spore_GerAC) | 5 | ALA B 201VAL B 140LEU B 216ALA B 193LEU B 130 | None | 1.13A | 4qrcA-3n54B:undetectable | 4qrcA-3n54B:21.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3nng | UNCHARACTERIZEDPROTEIN (Bacteroidesfragilis) |
PF00754(F5_F8_type_C) | 5 | ALA A 216VAL A 201CYH A 203LEU A 251PHE A 328 | None | 1.10A | 4qrcA-3nngA:undetectable | 4qrcA-3nngA:18.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3nuu | PKB-LIKE (Homo sapiens) |
PF00069(Pkinase) | 5 | ALA A 109GLU A 130MET A 134ARG A 204ASP A 223 | JOZ A 361 (-3.4A)SO4 A 5 (-3.1A)NoneSEP A 241 ( 3.4A)SO4 A 5 ( 4.5A) | 1.13A | 4qrcA-3nuuA:24.1 | 4qrcA-3nuuA:24.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3nuu | PKB-LIKE (Homo sapiens) |
PF00069(Pkinase) | 5 | ALA A 109GLU A 130MET A 134LEU A 196ARG A 204 | JOZ A 361 (-3.4A)SO4 A 5 (-3.1A)NoneNoneSEP A 241 ( 3.4A) | 0.80A | 4qrcA-3nuuA:24.1 | 4qrcA-3nuuA:24.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3nx4 | PUTATIVEOXIDOREDUCTASE (Salmonellaenterica) |
PF00107(ADH_zinc_N)PF08240(ADH_N) | 5 | ALA A 176VAL A 152LEU A 282ALA A 165LEU A 170 | None | 1.12A | 4qrcA-3nx4A:undetectable | 4qrcA-3nx4A:24.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3pfq | PROTEIN KINASE CBETA TYPE (Rattusnorvegicus) |
PF00069(Pkinase)PF00130(C1_1)PF00168(C2)PF00433(Pkinase_C) | 5 | ALA A 369GLU A 390LEU A 457ARG A 465ALA A 483 | ANP A 800 (-3.6A)NoneNoneTPO A 500 ( 2.9A)ANP A 800 ( 3.8A) | 1.14A | 4qrcA-3pfqA:16.5 | 4qrcA-3pfqA:19.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ppz | SERINE/THREONINE-PROTEIN KINASE CTR1 (Arabidopsisthaliana) |
PF07714(Pkinase_Tyr) | 5 | ALA A 576GLU A 596MET A 600LEU A 665ARG A 675 | STU A 1 (-3.3A)NoneNoneNoneSEP A 710 ( 3.6A) | 1.02A | 4qrcA-3ppzA:29.1 | 4qrcA-3ppzA:33.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3q4t | ACTIVIN RECEPTORTYPE-2A (Homo sapiens) |
PF00069(Pkinase) | 5 | ALA A 217GLU A 232LEU A 303ARG A 321ALA A 339 | TAK A 2 (-3.5A)TAK A 2 ( 4.9A)NoneNoneTAK A 2 ( 4.2A) | 1.12A | 4qrcA-3q4tA:24.7 | 4qrcA-3q4tA:28.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3s95 | LIM DOMAIN KINASE 1 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 5 | GLU A 384MET A 388LEU A 451ARG A 459ALA A 477 | STU A 1 (-3.7A)NoneNoneNoneSTU A 1 ( 4.1A) | 1.02A | 4qrcA-3s95A:26.1 | 4qrcA-3s95A:29.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3she | MAP KINASE-ACTIVATEDPROTEIN KINASE 3 (Homo sapiens) |
PF00069(Pkinase) | 5 | ALA A 71GLU A 84CYH A 120LEU A 157ARG A 165 | I85 A 350 (-3.3A)NoneI85 A 350 ( 3.8A)NoneNone | 0.95A | 4qrcA-3sheA:12.9 | 4qrcA-3sheA:25.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3tt0 | BASIC FIBROBLASTGROWTH FACTORRECEPTOR 1 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 8 | ALA A 512GLU A 531MET A 535VAL A 561LEU A 614CYH A 619ARG A 622ALA A 640 | 07J A 1 (-3.5A)07J A 1 (-3.8A)07J A 1 (-3.8A)07J A 1 (-4.7A)NoneNoneNone07J A 1 (-3.2A) | 0.63A | 4qrcA-3tt0A:39.4 | 4qrcA-3tt0A:67.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3tt0 | BASIC FIBROBLASTGROWTH FACTORRECEPTOR 1 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | GLU A 531MET A 535VAL A 561ARG A 622ALA A 640ASP A 641 | 07J A 1 (-3.8A)07J A 1 (-3.8A)07J A 1 (-4.7A)None07J A 1 (-3.2A)07J A 1 (-4.7A) | 1.36A | 4qrcA-3tt0A:39.4 | 4qrcA-3tt0A:67.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3txo | PROTEIN KINASE C ETATYPE (Homo sapiens) |
PF00069(Pkinase)PF00433(Pkinase_C) | 5 | ALA A 382GLU A 403LEU A 470ARG A 478ALA A 496 | 07U A 1 (-3.3A)07U A 1 ( 4.8A)NoneNone07U A 1 ( 4.0A) | 1.05A | 4qrcA-3txoA:14.0 | 4qrcA-3txoA:24.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3vid | VASCULAR ENDOTHELIALGROWTH FACTORRECEPTOR 2 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 5 | ALA A 866GLU A 885VAL A 916CYH A1024ARG A1027 | 4TT A2001 (-3.5A)NoneNoneNoneNone | 1.16A | 4qrcA-3vidA:35.1 | 4qrcA-3vidA:46.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3vid | VASCULAR ENDOTHELIALGROWTH FACTORRECEPTOR 2 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 5 | ALA A 866GLU A 885VAL A 916LEU A1019ASP A1046 | 4TT A2001 (-3.5A)NoneNoneNoneNone | 0.88A | 4qrcA-3vidA:35.1 | 4qrcA-3vidA:46.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3vid | VASCULAR ENDOTHELIALGROWTH FACTORRECEPTOR 2 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 5 | ALA A 866GLU A 885VAL A 916LEU A1019CYH A1024 | 4TT A2001 (-3.5A)NoneNoneNoneNone | 0.76A | 4qrcA-3vidA:35.1 | 4qrcA-3vidA:46.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3wzd | VASCULAR ENDOTHELIALGROWTH FACTORRECEPTOR 2 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 5 | ALA A 866GLU A 885VAL A 916LEU A1019CYH A1024 | LEV A1201 (-3.5A)LEV A1201 (-3.7A)LEV A1201 ( 4.6A)NoneDTT A1202 (-2.0A) | 0.49A | 4qrcA-3wzdA:28.9 | 4qrcA-3wzdA:50.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4a5o | BIFUNCTIONAL PROTEINFOLD (Pseudomonasaeruginosa) |
PF00763(THF_DHG_CYH)PF02882(THF_DHG_CYH_C) | 5 | ALA A 52VAL A 51LEU A 86ALA A 67LEU A 70 | None | 1.02A | 4qrcA-4a5oA:undetectable | 4qrcA-4a5oA:23.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4agd | VASCULAR ENDOTHELIALGROWTH FACTORRECEPTOR 2 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 5 | ALA A 866GLU A 885VAL A 916ARG A1027LEU A 802 | B49 A2000 (-3.5A)NoneB49 A2000 (-4.8A)NoneNone | 1.02A | 4qrcA-4agdA:35.2 | 4qrcA-4agdA:49.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4agd | VASCULAR ENDOTHELIALGROWTH FACTORRECEPTOR 2 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 5 | ALA A 866GLU A 885VAL A 916LEU A1019ARG A1027 | B49 A2000 (-3.5A)NoneB49 A2000 (-4.8A)NoneNone | 0.91A | 4qrcA-4agdA:35.2 | 4qrcA-4agdA:49.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4agd | VASCULAR ENDOTHELIALGROWTH FACTORRECEPTOR 2 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 5 | ALA A 866GLU A 885VAL A 916LEU A1019CYH A1024 | B49 A2000 (-3.5A)NoneB49 A2000 (-4.8A)NoneNone | 0.87A | 4qrcA-4agdA:35.2 | 4qrcA-4agdA:49.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ckr | EPITHELIAL DISCOIDINDOMAIN-CONTAININGRECEPTOR 1 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 7 | ALA A 653GLU A 672MET A 676LEU A 757ALA A 783ASP A 784PHE A 785 | DI1 A1000 (-3.6A)DI1 A1000 (-3.8A)DI1 A1000 (-3.6A)DI1 A1000 (-4.4A)DI1 A1000 (-3.7A)DI1 A1000 (-4.1A)DI1 A1000 (-4.5A) | 1.11A | 4qrcA-4ckrA:31.1 | 4qrcA-4ckrA:35.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ckr | EPITHELIAL DISCOIDINDOMAIN-CONTAININGRECEPTOR 1 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 7 | GLU A 672MET A 676LEU A 757ARG A 765ALA A 783ASP A 784PHE A 785 | DI1 A1000 (-3.8A)DI1 A1000 (-3.6A)DI1 A1000 (-4.4A)NoneDI1 A1000 (-3.7A)DI1 A1000 (-4.1A)DI1 A1000 (-4.5A) | 1.21A | 4qrcA-4ckrA:31.1 | 4qrcA-4ckrA:35.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4crs | SERINE/THREONINE-PROTEIN KINASE N2 (Homo sapiens) |
PF00069(Pkinase)PF00433(Pkinase_C) | 5 | ALA A 684GLU A 705LEU A 773ARG A 781ALA A 799 | AGS A1985 (-3.5A)NoneNoneTPO A 816 ( 3.0A)AGS A1985 ( 4.5A) | 0.86A | 4qrcA-4crsA:16.0 | 4qrcA-4crsA:27.37 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4e93 | TYROSINE-PROTEINKINASE FES/FPS (Homo sapiens) |
PF00017(SH2)PF07714(Pkinase_Tyr) | 5 | ALA A 588GLU A 607LEU A 674CYH A 679ARG A 682 | GUI A 901 (-3.4A)NoneNoneNoneNone | 1.08A | 4qrcA-4e93A:32.2 | 4qrcA-4e93A:33.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4f4p | TYROSINE-PROTEINKINASE SYK (Homo sapiens) |
PF07714(Pkinase_Tyr) | 5 | ALA A 400GLU A 420MET A 424LEU A 485ARG A 493 | 0SB A 701 (-3.3A)NoneNoneNoneSO4 A 702 (-3.0A) | 0.97A | 4qrcA-4f4pA:29.3 | 4qrcA-4f4pA:37.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fr4 | SERINE/THREONINE-PROTEIN KINASE 32A (Homo sapiens) |
PF00069(Pkinase) | 5 | ALA A 50GLU A 71VAL A 100LEU A 137ARG A 145 | STU A 401 (-3.2A)NoneNoneNoneNone | 0.60A | 4qrcA-4fr4A:21.4 | 4qrcA-4fr4A:21.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hvi | TYROSINE-PROTEINKINASE JAK3 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 853GLU A 871LEU A 940CYH A 945ARG A 948ALA A 966 | 19S A1201 (-3.3A)NoneNoneNoneNone19S A1201 ( 4.1A) | 0.98A | 4qrcA-4hviA:30.6 | 4qrcA-4hviA:33.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4k33 | FIBROBLAST GROWTHFACTOR RECEPTOR 3 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 7 | ALA A 506GLU A 525MET A 529VAL A 555ARG A 616ALA A 634ASP A 635 | ACP A 801 (-3.3A)ACP A 801 ( 4.8A)NoneACP A 801 (-4.7A)NoneNone MG A 802 ( 3.0A) | 1.23A | 4qrcA-4k33A:29.6 | 4qrcA-4k33A:77.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4k33 | FIBROBLAST GROWTHFACTOR RECEPTOR 3 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 7 | ALA A 506GLU A 525MET A 529VAL A 555LEU A 608ARG A 616ALA A 634 | ACP A 801 (-3.3A)ACP A 801 ( 4.8A)NoneACP A 801 (-4.7A)NoneNoneNone | 0.75A | 4qrcA-4k33A:29.6 | 4qrcA-4k33A:77.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4lg4 | SERINE/THREONINE-PROTEIN KINASE 3 (Homo sapiens) |
PF00069(Pkinase) | 5 | ALA A 54GLU A 70MET A 74LEU A 137ALA A 163 | GOL A 404 ( 3.1A)NoneNoneNoneGOL A 403 ( 3.0A) | 0.99A | 4qrcA-4lg4A:20.1 | 4qrcA-4lg4A:25.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mvf | CALCIUM-DEPENDENTPROTEIN KINASE 2 (Plasmodiumfalciparum) |
PF00069(Pkinase)PF13499(EF-hand_7) | 5 | ALA A 99GLU A 117MET A 121LEU A 183ARG A 191 | STU A 601 (-3.3A)NoneNoneNoneNone | 0.83A | 4qrcA-4mvfA:15.2 | 4qrcA-4mvfA:20.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4o27 | SERINE/THREONINE-PROTEIN KINASE 24 (Homo sapiens) |
PF00069(Pkinase) | 5 | ALA B 51GLU B 70LEU B 135ARG B 143ALA B 161 | ADP B 500 (-3.3A)NoneNoneNoneNone | 0.82A | 4qrcA-4o27B:19.9 | 4qrcA-4o27B:27.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4oav | PROTEIN (RNASE L) (Homo sapiens) |
PF00069(Pkinase)PF06479(Ribonuc_2-5A)PF12796(Ank_2)PF13857(Ank_5) | 5 | ALA B 390GLU B 404VAL B 434LEU B 475ALA B 502 | ACP B 801 (-3.2A)NoneACP B 801 (-4.8A)NoneNone | 0.99A | 4qrcA-4oavB:17.7 | 4qrcA-4oavB:18.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4opf | NRPS/PKS (Streptomycesalbus) |
PF00109(ketoacyl-synt)PF02801(Ketoacyl-synt_C) | 5 | ALA A6338LEU A6344ARG A6465ALA A6455LEU A6138 | None | 1.16A | 4qrcA-4opfA:undetectable | 4qrcA-4opfA:23.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4pxn | UNCHARACTERIZEDPROTEIN (Zea mays) |
PF00171(Aldedh) | 5 | ALA A 170VAL A 171CYH A 169ALA A 164LEU A 268 | NoneNoneNoneNAD A 601 (-3.3A)None | 1.17A | 4qrcA-4pxnA:undetectable | 4qrcA-4pxnA:25.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4rt7 | RECEPTOR-TYPETYROSINE-PROTEINKINASE FLT3 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 5 | ALA A 642GLU A 661LEU A 802CYH A 807ARG A 810 | P30 A1001 (-3.4A)P30 A1001 (-3.6A)NoneNoneNone | 1.01A | 4qrcA-4rt7A:28.4 | 4qrcA-4rt7A:40.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4tpt | LIM DOMAIN KINASE 2 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 5 | LEU A 442ARG A 450ALA A 468ASP A 469PHE A 470 | 35H A 701 ( 4.7A)None35H A 701 (-3.5A)35H A 701 (-4.7A)35H A 701 (-4.4A) | 0.83A | 4qrcA-4tptA:21.7 | 4qrcA-4tptA:29.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ueu | TYROSINE KINASE AS -A COMMON ANCESTOR OFSRC AND ABL (syntheticconstruct) |
PF07714(Pkinase_Tyr) | 5 | ALA A 35GLU A 52MET A 56LEU A 120ALA A 146 | ACP A1264 (-2.9A)NoneNoneNoneNone | 1.02A | 4qrcA-4ueuA:30.9 | 4qrcA-4ueuA:39.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wsq | AP2-ASSOCIATEDPROTEIN KINASE 1 (Homo sapiens) |
PF00069(Pkinase) | 5 | ALA A 72GLU A 90MET A 94LEU A 165ARG A 175 | KSA A 405 (-3.2A)NoneNoneNoneNone | 0.82A | 4qrcA-4wsqA:22.9 | 4qrcA-4wsqA:24.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4xcu | FIBROBLAST GROWTHFACTOR RECEPTOR 4 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 8 | ALA A 501GLU A 520MET A 524VAL A 550CYH A 552LEU A 603CYH A 608ALA A 629 | 40M A1002 ( 4.1A)40M A1002 (-3.7A)40M A1002 (-3.8A)40M A1002 (-4.7A)40M A1002 (-1.8A)NoneNone40M A1002 (-3.0A) | 0.32A | 4qrcA-4xcuA:39.0 | 4qrcA-4xcuA:90.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4xcu | FIBROBLAST GROWTHFACTOR RECEPTOR 4 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 501GLU A 520MET A 524VAL A 550LEU A 603LEU A 633 | 40M A1002 ( 4.1A)40M A1002 (-3.7A)40M A1002 (-3.8A)40M A1002 (-4.7A)NoneNone | 1.30A | 4qrcA-4xcuA:39.0 | 4qrcA-4xcuA:90.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4xuf | RECEPTOR-TYPETYROSINE-PROTEINKINASE FLT3 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 5 | ALA A 642GLU A 661ARG A 810ASP A 829PHE A 830 | P30 A1001 (-3.5A)P30 A1001 (-3.1A)NoneNoneP30 A1001 ( 4.1A) | 1.11A | 4qrcA-4xufA:33.7 | 4qrcA-4xufA:47.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4xuf | RECEPTOR-TYPETYROSINE-PROTEINKINASE FLT3 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 5 | ALA A 642GLU A 661LEU A 802ARG A 810PHE A 830 | P30 A1001 (-3.5A)P30 A1001 (-3.1A)NoneNoneP30 A1001 ( 4.1A) | 1.01A | 4qrcA-4xufA:33.7 | 4qrcA-4xufA:47.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5a46 | FIBROBLAST GROWTHFACTOR RECEPTOR 1(FMS-RELATEDTYROSINE KINASE 2,PFEIFFER SYNDROME),ISOFORM CRA_B (Homo sapiens) |
PF07714(Pkinase_Tyr) | 8 | ALA A 512GLU A 531MET A 535VAL A 561LEU A 614CYH A 619ARG A 622ALA A 640 | 38O A1769 (-3.6A)EDO A1766 (-4.1A)EDO A1766 (-3.5A)38O A1769 (-4.3A)NoneNoneNoneEDO A1766 ( 4.4A) | 0.76A | 4qrcA-5a46A:40.3 | 4qrcA-5a46A:64.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5a8f | HUMAN SAFFOLDVIRUS-3 VP2 (Cardiovirus B) |
PF00073(Rhv) | 5 | ALA C 87VAL C 82LEU C 198ALA C 251LEU C 208 | None | 1.16A | 4qrcA-5a8fC:undetectable | 4qrcA-5a8fC:22.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ci7 | SERINE/THREONINE-PROTEIN KINASE ULK1 (Homo sapiens) |
PF00069(Pkinase) | 5 | ALA A 44GLU A 63LEU A 129ARG A 137ALA A 164 | 51W A 401 (-3.4A)NoneNoneTPO A 180 ( 2.9A)None | 1.11A | 4qrcA-5ci7A:19.0 | 4qrcA-5ci7A:27.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5e4y | HOMOSERINEO-ACETYLTRANSFERASE (Pseudomonasveronii) |
PF00561(Abhydrolase_1) | 5 | ALA A 160VAL A 136ALA A 73ASP A 337LEU A 333 | None | 0.94A | 4qrcA-5e4yA:undetectable | 4qrcA-5e4yA:23.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5fm2 | PROTO-ONCOGENETYROSINE-PROTEINKINASE RECEPTOR RET (Homo sapiens) |
PF07714(Pkinase_Tyr) | 5 | ALA A 756GLU A 775VAL A 804LEU A 865ARG A 873 | PP1 A2012 (-3.2A)PP1 A2012 (-3.5A)PP1 A2012 (-4.5A)NoneSEP A 909 ( 3.0A) | 1.01A | 4qrcA-5fm2A:34.7 | 4qrcA-5fm2A:48.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5grn | PLATELET-DERIVEDGROWTH FACTORRECEPTOR ALPHA (Homo sapiens) |
PF07714(Pkinase_Tyr) | 5 | ALA A 625GLU A 644MET A 648LEU A 809CYH A 814 | 748 A1001 (-3.7A)748 A1001 (-3.3A)748 A1001 (-3.4A)748 A1001 ( 4.6A)748 A1001 (-3.4A) | 0.46A | 4qrcA-5grnA:26.2 | 4qrcA-5grnA:44.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5hor | HEPATOCYTE GROWTHFACTOR RECEPTOR (Homo sapiens) |
PF07714(Pkinase_Tyr) | 5 | ALA A1108MET A1131LEU A1195ARG A1203ALA A1221 | 63K A1401 (-3.5A)NoneNoneNone63K A1401 (-3.3A) | 1.05A | 4qrcA-5horA:24.7 | 4qrcA-5horA:32.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5idn | CYCLIN-DEPENDENTKINASE 8 (Homo sapiens) |
PF00069(Pkinase) | 5 | ALA A 50GLU A 66LEU A 142ARG A 150ALA A 172 | 6A7 A 401 (-3.3A)FMT A 404 ( 4.2A)NoneNone6A7 A 401 ( 4.1A) | 0.95A | 4qrcA-5idnA:15.9 | 4qrcA-5idnA:23.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5j5t | MITOGEN-ACTIVATEDPROTEIN KINASEKINASE KINASE KINASE3 (Homo sapiens) |
PF00069(Pkinase) | 5 | ALA A 43GLU A 61MET A 65LEU A 127ALA A 153 | 6G2 A 901 (-3.2A)NoneNoneNone6G2 A 901 ( 4.2A) | 0.80A | 4qrcA-5j5tA:22.2 | 4qrcA-5j5tA:23.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5j9z | EPIDERMAL GROWTHFACTOR RECEPTOR (Homo sapiens) |
PF07714(Pkinase_Tyr) | 5 | ALA A 743GLU A 762MET A 766LEU A 828ARG A 836 | 6HJ A1101 (-3.1A)6HJ A1101 ( 4.2A)6HJ A1101 ( 4.1A)NoneNone | 1.04A | 4qrcA-5j9zA:30.8 | 4qrcA-5j9zA:32.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kbr | SERINE/THREONINE-PROTEIN KINASE PAK 1 (Homo sapiens) |
PF00069(Pkinase) | 5 | ALA A 297GLU A 315MET A 319LEU A 380ARG A 388 | IPW A 601 (-3.5A)IPW A 601 (-3.9A)IPW A 601 (-4.1A)NoneNone | 0.88A | 4qrcA-5kbrA:22.3 | 4qrcA-5kbrA:27.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5l7n | PLEXIN-A1 (Mus musculus) |
PF01833(TIG) | 5 | ALA A 925VAL A 903LEU A 949ALA A 933LEU A 867 | None | 1.12A | 4qrcA-5l7nA:undetectable | 4qrcA-5l7nA:21.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ul4 | OXSB PROTEIN (Bacillusmegaterium) |
PF02310(B12-binding) | 5 | GLU A 364CYH A 318ARG A 317ALA A 400ASP A 401 | NoneSF4 A 801 (-2.2A)NoneNoneNone | 1.13A | 4qrcA-5ul4A:undetectable | 4qrcA-5ul4A:19.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6c0t | CGMP-DEPENDENTPROTEIN KINASE 1 (Homo sapiens) |
no annotation | 5 | ALA A 388GLU A 409MET A 413LEU A 475ARG A 483 | EE4 A 701 (-3.3A)DMS A 702 ( 4.2A)NoneNoneTPO A 517 ( 3.0A) | 1.05A | 4qrcA-6c0tA:16.3 | 4qrcA-6c0tA:14.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6c9d | SERINE/THREONINE-PROTEIN KINASEMARK1,SERINE/THREONINE-PROTEIN KINASEMARK1 (Homo sapiens) |
no annotation | 5 | ALA A 87GLU A 107MET A 111ARG A 181ALA A 199 | None | 0.75A | 4qrcA-6c9dA:22.4 | 4qrcA-6c9dA:14.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f5d | ATP SYNTHASE ALPHACHAIN, MITOCHONDRIALATP SYNTHASE SUBUNITBETA (Trypanosomabrucei) |
no annotation | 5 | VAL D 317LEU D 294ARG A 222ALA D 328LEU D 334 | None | 1.07A | 4qrcA-6f5dD:undetectable | 4qrcA-6f5dD:17.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6fek | PROTO-ONCOGENETYROSINE-PROTEINKINASE RECEPTOR RET (Homo sapiens) |
no annotation | 5 | ALA A 756GLU A 775VAL A 804LEU A 865ARG A 873 | ADN A1104 (-3.4A)NoneADN A1104 ( 4.6A)NoneFMT A1101 (-2.8A) | 1.05A | 4qrcA-6fekA:34.4 | 4qrcA-6fekA:25.13 |